Australian Market Slightly Higher

RTTNews | 340 วันที่ผ่านมา
Australian Market Slightly Higher

(RTTNews) - The Australian stock market is slightly higher on Thursday, recouping some of the losses in the previous two sessions, with the benchmark S&P/ASX 200 moving to a tad below the 7,100 level, despite the broadly negative cues from global markets overnight, boosted by gains in gold miners and technology stocks.

The benchmark S&P/ASX 200 Index is gaining 8.60 points or 0.12 percent to 7,099.90, after touching a high of 7,100.00 and a low of 7,077.90 earlier. The broader All Ordinaries Index is up 4.80 points or 0.07 percent to 7,278.30. Australian stocks ended sharply lower on Wednesday.

Among major miners, Fortescue Metals and Rio Tinto are down more than 1 percent each, while BHP Group is losing almost 1 percent and Mineral Resources is declining almost 3 percent.

Oil stocks are mostly lower. Santos and Beach energy are edging down 0.2 to 0.4 percent each, while Woodside Energy is losing almost 1 percent. Origin Energy is edging up 0.5 percent.

In the tech space, Zip and Xero are adding almost 1 percent each, while Afterpay owner Block is advancing almost 2 percent and WiseTech Global is gaining more than 1 percent. Appen is losing more than 1 percent.

Among the big four banks, Commonwealth Bank, National Australia Bank, Westpac and ANZ Banking are also edging down 0.2 to 0.3 percent each.

Among gold miners, Northern Star Resources and Gold Road Resources are gaining more than 2 percent each, while Newcrest Mining is advancing almost 3 percent and Resolute Mining is adding more than 1 percent. Evolution Mining is losing almost 1 percent.

In economic news, the manufacturing sector in Australia continued to contract in May, albeit at a slower rate, the latest survey from Judo Bank revealed on Thursday with a manufacturing PMI score of 48.4. That's up from 48.0, although it remains beneath the boom-or-bust line of 50 that separates expansion from contraction.

In the currency market, the Aussie dollar is trading at $0.649 on Thursday.

On Wall Street, stock ended weak on Wednesday after languishing in negative territory right through the day's session. The weakness in the market came as traders kept a close eye on developments regarding the bill to raise the U.S. debt ceiling and avoid potentially disastrous default.

The major averages all ended with moderate losses despite coming off the day's lows. The Dow ended the session at 32,908.27 with a loss of 134.51 points or 0.41 percent. The S&P 500 settled with a loss of 25.69 points or 0.61 percent at 4,179.83, while the Nasdaq ended down 82.14 points or 0.63 percent at 12,935.29.

The major European markets also showed significant moves to the downside on the day. The U.K.'s FTSE 100 ended 1.01 percent down, while Germany's DAX and France's CAC 40 both lost about 1.55 percent.

Crude oil prices fell sharply on Wednesday as worries about fuel demand resurfaced, while a stronger dollar also weighed on oil prices. West Texas Intermediate Crude oil futures for July slumped $1.37 or 2 percent at $68.09 a barrel.

read more
TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

Biotechnology company TC BioPharm (Holdings) plc (TCBP) announced Monday the execution of a non-binding letter of intent to acquire a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors.
RTTNews | 4 ชม. 13 นาทีที่ผ่านมา
Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Says Type II Variation Application For Opdivo + Yervoy Granted EMA Validation

Bristol Myers Squibb Co. (BMY) announced Monday that the European Medicines Agency (EMA) has validated its Type II variation application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment of adult patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).
RTTNews | 4 ชม. 52 นาทีที่ผ่านมา
Bay Street Likely To Open On Firm Note

Bay Street Likely To Open On Firm Note

Higher Canadian and U.S. futures, and rising crude oil and bullion prices point to a positive start on Bay Street Monday morning. Optimism about rate cuts by the Fed and several central banks in Europe is also expected to aid market's rise.
RTTNews | 4 ชม. 57 นาทีที่ผ่านมา
Healthcare Realty Inks Strategic JV Relationship Deal With KKR

Healthcare Realty Inks Strategic JV Relationship Deal With KKR

Healthcare Realty Trust Inc. (HR) announced Monday that it has entered into a strategic joint venture (JV) relationship with KKR & Co. Inc.(KKR) to jointly own and invest in quality medical outpatient buildings.
RTTNews | 5 ชม. 8 นาทีที่ผ่านมา
BioNTech Slips To Loss In Q1

BioNTech Slips To Loss In Q1

Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a net loss of 315.1 million euros or 1.31 euros per share for the first quarter, compared to net profit of 502.2 million euros or 2.05 euros per share in the prior-year quarter.
RTTNews | 5 ชม. 59 นาทีที่ผ่านมา
Eurozone Sentix Investor Confidence Rises For 7 Straight Months

Eurozone Sentix Investor Confidence Rises For 7 Straight Months

Eurozone investor confidence improved for the seventh straight month in May to hit the highest level since February 2022 as both current situation and expectations rose in small but steady steps, a closely watched survey showed on Monday. The investor confidence index posted -3.6 in May, the behavioral research institute Sentix reported. The score was forecast to improve moderately to -4.8.
RTTNews | 6 ชม. 8 นาทีที่ผ่านมา